NCT01462279View on ClinicalTrials.gov

Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Acute Respiratory Failure
Interventions
DRUG

Thiamine

200mg of intravenous thiamine in 50ml of D5W will be infused over 30 minutes once

Trial Locations (1)

02115

Beth Israel Deaconess Medical Center (BIDMC), Boston

All Listed Sponsors
collaborator

American Medical Association

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT01462279 - Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness | Biotech Hunter | Biotech Hunter